Exenatide once weekly improved 24-hour glucose control and reduced glycemic variability in metformin-treated patients with type 2 diabetes: a randomized, placebo-controlled trial

Click here to read the article.

Click here to download the pdf file.

/ Uncategorized

Share the Post

Our Response to COVID-19
X